648 related articles for article (PubMed ID: 26978581)
1. The prevalence, awareness, treatment and control of dyslipidemia among adults in China.
Pan L; Yang Z; Wu Y; Yin RX; Liao Y; Wang J; Gao B; Zhang L;
Atherosclerosis; 2016 May; 248():2-9. PubMed ID: 26978581
[TBL] [Abstract][Full Text] [Related]
2. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.
Zhang FL; Xing YQ; Wu YH; Liu HY; Luo Y; Sun MS; Guo ZN; Yang Y
Lipids Health Dis; 2017 Mar; 16(1):61. PubMed ID: 28330492
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP).
Opoku S; Gan Y; Fu W; Chen D; Addo-Yobo E; Trofimovitch D; Yue W; Yan F; Wang Z; Lu Z
BMC Public Health; 2019 Nov; 19(1):1500. PubMed ID: 31711454
[TBL] [Abstract][Full Text] [Related]
4. [Awareness rate, treatment rate and control rate of dyslipidemia in Chinese adults, 2010].
Li JH; Wang LM; Mi SQ; Zhang M; Li YC; Jiang Y; Xu Y; Dai M; Wang LH
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Aug; 46(8):687-91. PubMed ID: 23157860
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.
Liu X; Yu S; Mao Z; Li Y; Zhang H; Yang K; Zhang H; Liu R; Qian X; Li L; Bie R; Wang C
Lipids Health Dis; 2018 May; 17(1):119. PubMed ID: 29788966
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese.
Song P; Zha M; Yang X; Xu Y; Wang H; Fang Z; Yang X; Xia W; Zeng C
Atherosclerosis; 2019 Mar; 282():57-66. PubMed ID: 30690298
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of dyslipidemia and associated risk factors among adults aged ≥35 years in northern China: a cross-sectional study.
Xi Y; Niu L; Cao N; Bao H; Xu X; Zhu H; Yan T; Zhang N; Qiao L; Han K; Hang G; Wang W; Zhang X
BMC Public Health; 2020 Jul; 20(1):1068. PubMed ID: 32631296
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of dyslipidemia and associated risk factors among rural Chinese adults.
Sun GZ; Li Z; Guo L; Zhou Y; Yang HM; Sun YX
Lipids Health Dis; 2014 Dec; 13():189. PubMed ID: 25496459
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China.
Cai L; Zhang L; Liu A; Li S; Wang P
J Atheroscler Thromb; 2012; 19(2):159-68. PubMed ID: 22041495
[TBL] [Abstract][Full Text] [Related]
10. Awareness, treatment, control, and determinants of dyslipidemia among adults in China.
Opoku S; Gan Y; Yobo EA; Tenkorang-Twum D; Yue W; Wang Z; Lu Z
Sci Rep; 2021 May; 11(1):10056. PubMed ID: 33980884
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of dyslipidemia and associated factors among the hypertensive population from rural Northeast China.
Yu S; Yang H; Guo X; Zhang X; Zheng L; Sun Y
BMC Public Health; 2015 Nov; 15():1152. PubMed ID: 26589291
[TBL] [Abstract][Full Text] [Related]
12. The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China.
Ge P; Dong C; Ren X; Weiderpass E; Zhang C; Fan H; Zhang J; Zhang Y; Xi J
PLoS One; 2015; 10(12):e0144104. PubMed ID: 26640891
[TBL] [Abstract][Full Text] [Related]
13. Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study.
He H; Yu YQ; Li Y; Kou CG; Li B; Tao YC; Zhen Q; Wang C; Kanu JS; Huang XF; Han M; Liu YW
Lipids Health Dis; 2014 Aug; 13():122. PubMed ID: 25086650
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and risk factors of dyslipidemia in a rural population of Henan Province, China].
Zhou JM; Luo XP; Wang S; Yin L; Pang C; Wang GA; Shen YX; Wu DT; Zhang L; Ren YC; Wang BY; Yang XY; Zhang HY; Han CY; Zhao Y; Li LL; Wang CJ; Feng TP; Zhao JZ; Hu DS; Zhang M
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):799-805. PubMed ID: 27655600
[No Abstract] [Full Text] [Related]
15. [Prevalence and awareness of dyslipidemia among overweight and obese population in Beijing community].
Fu YY; Yu JM; Wang JH; Wang JS; Sun YH; Liu HF; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):562-6. PubMed ID: 21033142
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia in Shanghai, China.
Wu JY; Duan XY; Li L; Dai F; Li YY; Li XJ; Fan JG
Prev Med; 2010 Nov; 51(5):412-5. PubMed ID: 20817022
[TBL] [Abstract][Full Text] [Related]
17. [A cross-sectional study on the prevalence and related factors of dyslipidemia among adults in Anhui province, in 2015].
Xu W; Xing XY; He Q; Dai D; Li R; Xu JQ; Chen YJ; Liu ZR
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Feb; 41(2):195-200. PubMed ID: 32164129
[No Abstract] [Full Text] [Related]
18. Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China.
Yan L; Xu MT; Yuan L; Chen B; Xu ZR; Guo QH; Li Q; Duan Y; Huang Fu J; Wang YJ; Zhang M; Luo ZJ; Zhao WG; Wang YM; Yuan ZF; Wang WQ; Wang PH; Ran XW; Wang YJ; Yang HZ; Gao L; Chen WQ; Ning G
J Clin Lipidol; 2016; 10(1):150-60. PubMed ID: 26892132
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and association with diabetes and obesity of lipid phenotypes among the hypertensive Chinese rural adults.
Zhang X; Sun Z; Zhang D; Zheng L; Li J; Liu S; Xu C; Li J; Hu D; Sun Y
Heart Lung; 2009; 38(1):17-24. PubMed ID: 19150527
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hypertension and associated risk factors in Dehui City of Jilin Province in China.
Wei Q; Sun J; Huang J; Zhou HY; Ding YM; Tao YC; He SM; Liu YL; Niu JQ
J Hum Hypertens; 2015 Jan; 29(1):64-8. PubMed ID: 24990419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
